Skip to main content
. 2022 Feb 28;20(1):1–16. doi: 10.9758/cpn.2022.20.1.1

Table 2.

Studies published in English included for systematic review

Author/ Country Methodology Subject characteristics Indication for ECT ECT technique Cognitive measurements Assessment schedule Cognitive outcome Risk of bias GRADE rating
Chatterjee and Mohammed [11] (1980)/ India Non-ran-domized, single-blind trial n = 120, age range 16−50 years 10 Major de-pression, 30 Schizophrenia in each treatment group 1. Bitemporal
2. Unilateral non-dominant hemisphere
3. Unilateral dominant hemisphere
Fixed dose, unknown pulse-width
7 subtests from Indian version of Boston Memory Scale
1. Digit forward
2. Digit backward
3. Personal data (remote)
4. Personal data (recent
5. Common knowledge
6. Counting 20 to 1
7. Paired associates
1. Pre-ECT
2. 3 weeks after treatment completion
Within-group comparison showed significant improvement for group 2 only
Schizophrenia memory score change 6.57 ± 13.44
Depression mean memory score change 4.50 ± 5.66
Between-group comparison showed no significant difference overall
Between-group comparison showed significant improvement in immediate auditory verbal recall (mean change 0.88 ± 1.88) and memory dependent learning (mean change 2.19 ± 5.46) for group 2
High (non-ran-domized, rater-bias) Low
Bagadia et al. [10] (1981)/ India Double-blind controlled n = 40, age range 18−65 years 20 Depression, 20 Schizophrenia 1. Bitemporal with placebo, fixed dose, pulse-width unknown (n = 20, 10 depressed and 12 schizophrenic)
2. Simulated ECT with imipramine for Depression or chlorpromazine for Schizophrenia (n = 20, 10 depressed and 8 schizophrenic)
1. Koh’s Block Design Test
2. Picture Recognition Test
3. Bender Gestalt Test
4. Arithmetic
5. Immediate memory (digits)
6. Sentence Repetition
7. Remote memory
8. Recent memory
1. Pre-ECT
2. 48 hours after treatment completion
No significant change in cognitive test scores in both groups
Significant improvement in Koh’s Block Design Test regardless of ECT when analysed by diagnosis group
Depression: ECT with placebo
Mean percent change 52.22 ± 50.39, p < 0.01
Depression: simulated ECT with imipramine
Mean percent change 44.08 ± 48.43, p < 0.05
Schizophrenia: ECT with placebo
Mean percent change 38.5 ± 33.2, p < 0.05
Schizophrenia: simulated ECT with chlorpromazine
Mean percent change 20.1 ± 15.8, p < 0.05
High (not randomized) Low
Bagadia et al. [21] (1988)/ India Double-blind, randomized trial n = 40, age range 18−65 years Schizophrenia 1.Bitemporal (n = 20)
2.Right unilateral (n = 20)
Fixed dose, pulse-width unknown, first 3 sessions in 2-day intervals, next 3 at 4-day intervals
Specially developed cognitive battery to assess learning, unaided recall, recognition and confabulation 1. Pre-ECT
2. After 3 sessions
3. After 6 sessions
Specific score not reported.
Authors reported memory improvement in 40% of sample and impairment in 30% of sample, similar rates in both treatment groups
High (randomiza-tion, alloca-tion, rater- blinding not mentioned) Very low
Fujita et al. [22] (2006)/Japan Retrospective naturalistic cohort n = 18, mean age 49.8 ± 9.9 years Major depression, Bipolar disorder (I or II) 6−12 sessions of:
1.Bitemporal sine wave at fixed-dose with stepwise increments until seizure induced, mean of 9.9 ± 2.8 sessions
2.Bitemporal pulse-wave at aged-based dose with stepwise increments until seizure induced, mean of 11.0 ± 2.0 sessions
1. MMSE
2. WMS-Revised
3. TMT A and B
4. Stroop Test
5. Verbal and Letter Fluency
6. Digit Symbol
7. Dual task
1. 3−14 days pre-ECT
2. 3−14 days after treatment completion (mean 8.2 SD 3.5 days)
No significant change in pre- and post-ECT MMSE and WMS scores. Significant improvement in Visual memory (57.9 ± 5.0 vs. 61.6 ± 5.1) and General Memory (113.7 ± 19.9 vs. 127.7 ± 25.3) for the pulse wave group.
Impaired attention/executive function for the sine wave ECT group, (errors on Stroop Test 0.9 ± 0.6 vs. 2.3 ± 1.1 and Dual Task 88.5 ± 4.3 vs. 78.9 ± 7.6).
Attention/Executive function scores improved for the pulse-wave group (Dual Task 77.2 ± 11.1 vs. 88.2 ± 7.3)
The between-group difference in Dual Task performance was significant
High (no controls) Very low
Kunigiri et al. [23] (2007)/ India Observational n = 15, mean age 31.6 ± 6.5 years Major depression with melancholia 1.Bitemporal (n = 10)
2.Right unilateral (n = 5)
Suprathreshold dosing, pulse-width unknown, 3 times per week
1. Orientation Battery Test (OBT)
2. TMT A
3. Verbal Paired Associates from WMS
4. Verbal Learning Test
5. Passage Test
6. Benton Visual Retention Test
1. Within 48 hours before first ECT
2. After 20 mins, 50 mins, 2 hours and 8 hours after the second and fifth sessions for the Orientation Battery Test and TMT
3. 8 hours after second and fifth sessions for memory tests
Orientation and TMT scores declined at 20 mins then recovered by 8 hours post-ECT.
After second session: OBT = 12 ± 0.0 vs. 6.6 ± 2.7 vs. 9.6 ± 1.6 vs. 10.8 ± 1.4 vs. 11.8 ± 0.4
TMT = 66.8 ± 27.3 vs. 139.6 ± 78.5 vs. 92.2 ± 63.9 vs. 63.9 ± 18.9 vs. 61.9 ± 20.3
After fifth session: OBT = 12 ± 0.0 vs. 4.9 ± 3.0 vs. 9.3 ± 2.0 vs. 10.3 ± 2.6 vs. 11.7 ± 0.6
TMT = 66.8 ± 27.3 vs. 135.1 ± 109.4 vs. 98.1 ± 71.6 vs. 74.8 ± 43.3 vs. 60.8 ± 19.8
Significant decline in all memory scores
Verbal Paired Associates
9.1 (0.9) vs. 5.9 (1.4) vs. 5.3 (1.8)
Verbal Learning
9.8 ± 1.0 vs. 6.2 ± 2.6 vs. 4.3 ± 1.6
Passage Test
14.9 ± 1.7 vs. 15.7 ± 3.3 vs. 9.6 ± 3.5
BVRT
8.8 ± 0.8 vs. 8.3 ± 0.8 vs. 7.7 ± 1.5
High (no controls) Very low
Prakash et al. [13] (2015)/ India Observational n = 40, mean age 34.6 ± 3.7 years
Depression, Non-affective psychotic disorders
Bitemporal, brief pulse, dosing and pulse-width unknown, twice weekly TMT and B 1. Pre-ECT
2. After treatment completion
3. 4 weeks after treatment completion
Significant improvement by 4 weeks after ECT
TMT A:
22.20 ± 3.63 vs. 19.85 ± 2.91 vs. 17.52 ± 3.23
TMT B:
50.75 ± 6.84 vs. 46.62 ± 6.33 vs. 45.95 ± 6.53
High (no controls) Very low
Tor et al. [15] (2017)/ Singapore Retrospective naturalistic cohort n = 48, mean age 43.74 ± 10.82 years Schizophrenia 1. Bitemporal (n = 17) age-based dosing, 0.5 ms pulse-width, mean 9.5 (3.4) sessions
2. Right unilateral (n = 10) stimulus titration, 0.5 ms pulse-width, mean 8.0 ± 3.3 sessions
3. Bitemporal (n = 10) stimulus titration, 0.5 ms pulse-width mean 11.3 ± 1.9 sessions
4. Bifrontal (n = 11) stimulus titration, 1.0 ms pulse-width, mean 11.6 ± 3.8 sessions
Montreal Cognitive Assessment (MoCA) total score and score of delayed recall item 1. 1−2 days pre-ECT
2. 1−2 days after treatment completion
Group 1 showed significant decline in delayed recall.
1.88 ± 1.93 vs. 0.59 ± 1.12
Group 3 showed significant improvement in total score.
16.3 ± 11.0 vs. 24.0 ± 5.0
General significant overall improvement in total MoCA score with no significant between group differences. 16.8 ± 9.1 vs. 20.7 ± 6.0
High (no controls) Very low

Values are presented as mean ± standard deviation.

ECT, electroconvulsive therapy; GRADE, Grading of Recommendations, Assessment, Development and Evaluation; MMSE, Mini-Mental State Exam; WMS, Wechsler Memory Scale; TMT, Trail Making Tests; SD, standard deviation.